Shenyang Xingqi Pharmaceutical Co Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shenyang Xingqi Pharmaceutical Co Ltd with three other
companies in this sector in China:
Coland Holdings Limited
sales of 468.95 million Chinese Renmimbi [US$66.24 million]
of which 100%
was Pharmaceutical Preparation Manufacturing),
Fujian Cosunter Pharmaceutical Co Ltd
(402.40 million Chinese Renmimbi [US$56.84 million]
of which 100%
was Medicine), and
Lansen Pharmaceutical Holdings Limited
(376.56 million Chinese Renmimbi [US$53.19 million]
of which 84%
was Specialty Pharmaceuticals).
During the year ended December of 2018, sales at
Shenyang Xingqi Pharmaceutical Co Ltd were 431.20 million Chinese Renmimbi (US$60.91 million).
increase of 19.8%
versus 2017, when the company's sales were 360.01 million Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shenyang Xingqi Pharmaceutical Co Ltd
(and since 2013, sales have increased a total of 97%).
Sales of Pharmaceutical Manufacturing Industry saw an increase
19.9% in 2018, from
359.16 million Chinese Renmimbi to 430.69 million Chinese Renmimbi.
Not all segments of Shenyang Xingqi Pharmaceutical Co Ltd experienced an increase in sales in 2018:
sales of Others fell 38.9% to 515,304.35 Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).